Roche to present new OCREVUS (ocrelizumab) data in multiple sclerosis and continued research into neuromyelitis optica spectrum disorder at ECTRIMS 2022 October 19, 2022October 19, 2022 by / Share This.....LinkedinTwitterFacebookGoogleEmailRelated News: New data for Roche’s OCREVUS (ocrelizumab) show…Data at the 2022 ASCO Annual Meeting highlight…Data at the 2022 ASCO Annual Meeting highlight…Data at the 2022 ASCO Annual Meeting highlight…New data for Roche’s Columvi and Lunsumio presented…Roche to present data at ASH 2022 showcasing…
